Akorn Sues Fresenius Over Nixed $4.3B Merger
Akorn Pharmaceuticals Inc. on Monday sued Fresenius Kabi AG in Delaware Chancery Court for ending a $4.3 billion merger of the companies over alleged violations of U.S. Food and Drug Administration...To view the full article, register now.
Already a subscriber? Click here to view full article